A Reappraisal of Economic Evaluation of Pharmaceuticals: Science or Marketing?
Year of publication: |
1998
|
---|---|
Authors: | Drummond, Michael F. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 14.1998, 1, p. 1-9
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Pharmacoeconomics | Pharmaceutical-industry | Marketing | Clinical-trial-design-commentary | Practice-guideline-commentary |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Pharmacoeconomics in the New Millennium: A Pharmaceutical Industry Perspective
Thwaites, Rob, (1998)
-
The Role of Pharmacoeconomic Evaluations in Disease Management
Chang, Kenneth, (1998)
-
Mega-Mergers in the Pharmaceutical Industry: In Whose Interests?
Po, Alain Li Wan, (1998)
- More ...
-
Methods for the Economic Evaluation of Health Care Programmes
Drummond, Michael F.,
-
Drummond, Michael F., (2002)
-
Time for a change in drug licensing requirements?
Drummond, Michael F., (2002)
- More ...